The Global CEO Initiative on Alzheimer’s Disease (CEOi)
In October 2023, an important milestone was reached as worldwide experts gathered for the Lausanne X Workshop. Over the past decade, CEOi and the Lausanne Dialogues have driven significant progress, establishing themselves as the premier global platforms for bringing people together across sectors, countries, and specialties, and successfully raising the alarm about the need for a global ecosystem and action plan.
Check out our meeting summary here to learn about key takeaways from Lausanne X.
The Global CEO Initiative on Alzheimer’s Disease (CEOi), founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. The CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s.
Our members and collaborators
Blood-Based Biomarker Workgroup
Lessons and Opportunities for the Alzheimer’s Community
Reflections on COVID-19
A new podcast on stopping Alzheimer’s: A growing pandemic
In this episode, current and former regulatory officials take a page from the COVID-19 playbook, highlighting the vital need for transparent communication and cooperation across all stakeholders. The opportunity when done right?: The advancement of incremental innovations that can eventually transform a devastating disease into a manageable condition.